July 25, 2024 – Page 9 – Goldea Capital

West Bancorporation, Inc. Announces Second Quarter 2024 Financial Results and Declares Quarterly Dividend

Written by Customer Service on July 25, 2024. Posted in Earnings Releases And Operating Results.

WEST DES MOINES, Iowa, July 25, 2024 (GLOBE NEWSWIRE) — West Bancorporation, Inc. (Nasdaq: WTBA; the “Company”), parent company of West Bank, today reported second quarter 2024 net income of $5.2 million, or $0.31 per diluted common share, compared to first quarter 2024 net income of $5.8 million, or $0.35 per diluted common share, and second quarter 2023 net income of $5.9 million, or $0.35 per diluted common share. On July 24, 2024, the Company’s Board of Directors declared a regular quarterly dividend of $0.25 per common share. The dividend is payable on August 21, 2024, to stockholders of record on August 7, 2024. David Nelson, President and Chief Executive Officer of the Company, commented, “Our credit quality remains pristine as a result of our disciplined loan growth and credit risk management practices. The ratio of nonperforming...

Lloyds Bank plc: 2024 Half-Year Results

Written by Customer Service on July 25, 2024. Posted in Earnings Releases And Operating Results.

LONDON, July 25, 2024 (GLOBE NEWSWIRE) — Member of the Lloyds Banking Group CONTENTS Financial review 1 Risk management Principal risks and uncertainties 3 Capital risk 4 Credit risk 8 Liquidity risk 18 Statutory information Condensed consolidated half-year financial statements (unaudited) 21 Condensed consolidated income statement (unaudited) 22 Condensed consolidated statement of comprehensive income (unaudited) 23 Condensed consolidated balance sheet (unaudited) 24 Condensed consolidated statement of changes in equity (unaudited) 25 Condensed consolidated cash flow statement (unaudited) 28 Notes to the condensed consolidated half-year financial statements (unaudited) 29 Statement of directors’ responsibilities 58 Independent...

FirstService Reports Second Quarter 2024 Results

Written by Customer Service on July 25, 2024. Posted in Earnings Releases And Operating Results.

Strong Top-Line Growth Drives Financial Performance Operating highlights: Three months ended Six months ended June 30 June 30 2024 2023 2024 2023 Revenues (millions) $ 1,297.5 $ 1,119.7 $ 2,455.5 $ 2,138.2 Adjusted EBITDA (millions) (note 1) 132.5 118.4 215.9 200.4 Adjusted EPS (note 2) 1.36 1.46 2.03 2.31 GAAP Operating Earnings 83.9 82.3 122.0 123.3 GAAP EPS 0.78 1.01 0.92 1.37 TORONTO, July 25, 2024 (GLOBE NEWSWIRE) — FirstService Corporation (TSX: FSV; NASDAQ: FSV) today reported results for its second quarter ended June 30, 2024. All amounts are in US dollars. Consolidated revenues for the second quarter were $1.30 billion,...

FTI Consulting Reports Record Second Quarter 2024 Financial Results

Written by Customer Service on July 25, 2024. Posted in Earnings Releases And Operating Results.

Second Quarter 2024 Revenues of $949.2 Million, Up 10% Compared to $864.6 Million in Prior Year Quarter Second Quarter 2024 EPS of $2.34, Up 34% Compared to $1.75 in Prior Year Quarter Company Raises Full Year 2024 Revenue and EPS Guidance Ranges to Reflect Record First Half of 2024 WASHINGTON, July 25, 2024 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today released financial results for the second quarter ended June 30, 2024. Second quarter 2024 revenues of $949.2 million increased $84.6 million, or 9.8%, compared to revenues of $864.6 million in the prior year quarter. The increase in revenues was primarily due to higher demand in the Corporate Finance & Restructuring, Economic Consulting and Technology segments. Net income of $83.9 million compared to $62.4 million in the prior year quarter. The increase in net...

Carpenter Technology Reports Fourth Quarter and Fiscal Year 2024 Results

Written by Customer Service on July 25, 2024. Posted in Public Companies.

Exceeded Fourth Quarter Operating Income Guidance Delivered Most Profitable Year in Company History Strong Fourth Quarter Adjusted Free Cash Flow Pulling Operating Income Target Forward 2 Years to Fiscal Year 2025 Authorized Share Repurchase Program PHILADELPHIA, July 25, 2024 (GLOBE NEWSWIRE) — Carpenter Technology Corporation (NYSE: CRS) (the “Company”) today announced financial results for the fiscal fourth quarter and year ended June 30, 2024. For the quarter, the Company reported operating income of $108.3 million, and earnings per diluted share of $1.85. Excluding special items discussed below, adjusted operating income was $125.2 million and adjusted earnings per diluted share was $1.82 for the current quarter. Fourth Quarter Highlights Delivered $125.2 million of adjusted operating income, up 39 percent sequentially and...

Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia

Written by Customer Service on July 25, 2024. Posted in Public Companies.

Fast Track is designed to expedite FDA review of important new drugs to treat serious conditions and fill an unmet medical need Fast Track designation for Tonmya recognizes fibromyalgia as a serious condition impacting more than 10 million U.S. adults NDA submission on track for second half 2024 Tonmya has the potential to be the first new drug for treating fibromyalgia in more than 15 years CHATHAM, N.J., July 25, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the management of fibromyalgia. Tonmya is a non-opioid,...

Hydrofarm Holdings Group, Inc. to Announce Second Quarter 2024 Results on August 8, 2024

Written by Customer Service on July 25, 2024. Posted in Public Companies.

SHOEMAKERSVILLE, Pa., July 25, 2024 (GLOBE NEWSWIRE) — Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (“CEA”), today announced that it will host a conference call to review second quarter 2024 results on Thursday, August 8, 2024 at 8:30 AM ET. A press release containing second quarter 2024 results will be issued before market open that same day. The conference call can be accessed live over the phone by dialing 1-800-267-6316 and entering the conference ID: HYFMQ2. The conference call will also be webcast live and archived on the corporate website at www.hydrofarm.com, under the “Investors” section. About Hydrofarm Holdings Group, Inc.Hydrofarm is a leading independent...

Inotiv, Inc. to Report Fiscal 2024 Third Quarter Financial Results and Host Conference Call on Thursday, August 8, 2024

Written by Customer Service on July 25, 2024. Posted in Public Companies.

WEST LAFAYETTE, Ind., July 25, 2024 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2024 third quarter ended June 30, 2024, on Thursday, August 8, 2024, after the close of the stock market. The Company will host a conference call that same day at 4:30 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing: 1-800-225-9448 (Domestic) 1-203-518-9708 (International) INOTIV (Conference ID) The live conference call webcast will be accessible in the Investors section of the Company’s web site and directly via the...

Lexicon Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 1, 2024

Written by Customer Service on July 25, 2024. Posted in Public Companies.

THE WOODLANDS, Texas, July 25, 2024 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its second quarter 2024 financial results on Thursday, August 1, 2024 after the markets close. Management will conduct a conference call and live webcast at 5:00 p.m. ET (4:00 p.m. CT) that day to discuss the financial results and to provide a business update. Dial-in InformationU.S. Dial-in Number: (888) 317-6003International Dial-in Number: (412) 317-6061Conference ID: 7023126 Replay InformationU.S. Dial-in Number: (877) 344-7529Replay International Dial-in Number: (412) 317-0088Conference ID: 3907883 The dial-in replay will be available for 7 days following the call. An audio webcast will be available online at www.lexpharma.com/events, with a webcast replay accessible for 14 days after the call. About Lexicon Pharmaceuticals Lexicon...

Windtree Therapeutics Provides Update on Istaroxime Clinical Development and Upcoming Clinical Trial Data

Written by Customer Service on July 25, 2024. Posted in Public Companies.

Nearing completion of enrollment, the SEISMiC Extension Phase 2b study in early cardiogenic shock patients is set to deliver new data WARRINGTON, Pa., July 25, 2024 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced an update of istaroxime in both clinical and business development. Istaroxime is a novel first-in-class therapy that is designed to improve systolic contraction and diastolic relaxation of the heart while also increasing blood pressure and maintaining or improving renal function. It has been studied in three positive Phase 2 trials enrolling patients with acute heart failure (AHF) and early cardiogenic shock. In line with previous guidance,...

Day: July 25, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice